BioSpace News Archive

Pharm Country

Shils Fund Hosts Social Entrepreneur Leadership Conference And UPenn Dental Student Competition At Its 16th Annual Awards Event

The Dr. Edward B. Shils Entrepreneurial Fund, Inc., a nonprofit organization dedicated to innovation in health care and named after the late Dr. Edward B. Shils, held its 16th annual awards ceremony and a new Social Entrepreneur Leadership conference on October 4 at the Union League in Philadelphia.

October 18, 2018
·
6 min read
Business

Daniel Kolk, Ph.D., Joins XCR Diagnostics, Inc.

Kolk will be responsible for Clinical Assay Development, Assay Integration and Clinical Trials.

October 18, 2018
·
2 min read
Genetown

4G Clinical Named One of the 2018 Best Small & Medium Workplaces by Great Place to Work® and FORTUNE

The ranking considered more than 112,000 employee surveys from small and medium-sized companies.

October 18, 2018
·
3 min read
Biotech Beach

Trovagene to Provide Update on Onvansertib Clinical Development Program on Wednesday, October 24, 2018

Webcast and Conference Call for Investors and Analysts on Wednesday, October 24th at 8:30 am EDT

October 18, 2018
·
6 min read
Biotech Beach

Youngevity’s Hemp FX™ Now Available for Purchase Online

YGYI, Inc. (NASDAQ:YGYI), a leading omni-direct lifestyle company, announces that its hemp-derived cannabidiol (CBD) Hemp FX products are now available for purchase online at the fully transactional website https://www.hempfx.com/.

October 18, 2018
·
4 min read
Business

New Online Breast Cancer Resource Puts Women in Control of Their Breast Cancer Treatment

Helps Patients Make Informed Choices

October 18, 2018
·
2 min read
‘Dementia-friendly’ digital reading platform wins Canada-wide competition

A new app designed to help people with later-stage dementia to continue reading has won the AGE-WELL National Impact Challenge.

October 18, 2018
·
3 min read
Biotech Beach

Amgen Invests £50 Million ($66 Million) In Oxford Nanopore Technologies

Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology.

October 18, 2018
·
8 min read
BioCapital

Executive Leaders from The Obesity Society Travel to Oman

Officers to Address Obesity Treatment, Nutrition; and Obesity Issues in Women and Children

October 18, 2018
·
3 min read
FDA

Albireo Receives FDA Fast Track Designation for A4250

Fast Track designation to lead product candidate A4250, an ileal bile acid transporter inhibitor, which is being developed for the treatment of progressive familial intrahepatic cholestasis (PFIC), a rare and life-threatening liver disease with no approved pharmacologic treatment option.

October 18, 2018
·
7 min read